Anascorp 66621-0150
Generic: Centruroides (scorpion) Immune F(ab)2 (equine)
Product NDC
66621-0150- Manufacturer
- Rare Disease Therapeutics, Inc
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Plasma Derivative
- Marketing Start
- August 3, 2011
- Listing Expires
- December 31, 2026
- Application
- BLA125335
Active Ingredients
| Ingredient | Strength |
|---|---|
| Centruroides Fab2 Antivenin (equine) | 7 mg/mL |
Drug Class
Antivenin [EPC]Antivenins [CS]Passively Acquired Immunity [PE]
Packaging Options(1)
1 VIAL in 1 CARTON (66621-0150-2) / 10 mL in 1 VIAL (66621-0150-1)